Cape Biotechnology (300639.SZ) announced its performance for the first half of the year, turning losses into a profit of 31.2621 million yuan.

According to the Zhitong Finance APP, Capstone Biology (300639.SZ) has released its semi-annual report for 2026. During the reporting period, the company achieved operating revenue of 300 million yuan, a year-on-year decrease of 4.74%. It achieved a net profit attributable to shareholders of the listed company of 31.2621 million yuan. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 12.1304 million yuan. The basic earnings per share was 0.0484 yuan.